Neurogene (NGNE) Accumulated Depreciation (2013 - 2018)

Neurogene has reported Accumulated Depreciation for 6 years, with the latest figure at $443000.0 in Q4 2018.

• For the quarter ending Q4 2018, Accumulated Depreciation fell 17.2% year-over-year to $443000.0; the trailing twelve-month figure through Dec 2018 stood at $443000.0 (down 17.2% YoY), and the FY2018 full-year result was $443000.0, down 17.2% from the prior year.
• Accumulated Depreciation for Q4 2018 stood at $443000.0, down from $535000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation was $535000.0 in Q4 2017, with the low at $90000.0 in Q4 2015.
• Historically, Accumulated Depreciation has averaged $304000.0 across 5 years, with a median of $277000.0 in 2014.
• Annual changes were most pronounced in 2015 — Accumulated Depreciation slumped 67.51% — and 2017, when it surged 205.71%.
• Neurogene's Accumulated Depreciation stood at $277000.0 in 2014, then tumbled by 67.51% to $90000.0 in 2015, then soared by 94.44% to $175000.0 in 2016, then surged by 205.71% to $535000.0 in 2017, then dropped by 17.2% to $443000.0 in 2018.
• The last three Accumulated Depreciation figures came in at $443000.0 (Q4 2018), $535000.0 (Q4 2017), and $175000.0 (Q4 2016), per Business Quant data.